I. Executive Summary
2,3-Dibromopropionyl chloride (CAS 18791-02-1) is a highly reactive bifunctional intermediate combining an acid chloride with a vicinal dibromide, formula C3H3Br2ClO and molecular weight 250.32. Supplied as a colourless to pale straw-coloured liquid, it is used as an acylating and alkylating building block in pharmaceutical and agrochemical development. Volumes are small and campaign-based, buyers are almost exclusively process chemists and contract development and manufacturing organisations, and the deciding purchasing criteria are containment capability, specification discipline and documentation rather than price.
Three characteristics determine how the product must be handled commercially. It is corrosive, with skin-corrosion classification under the Globally Harmonized System and the GHS05 pictogram. It is moisture-sensitive, liberating hydrogen chloride on contact with water or humidity, which makes hydrolytic stability the central quality parameter. And it combines two electrophilic functionalities, so downstream users treat it as a potential alkylating agent requiring occupational exposure banding and containment.
For exporters, this translates into a specific set of obligations: EU REACH registration or Only Representative coverage, TSCA active status with Section 13 import certification, accurate corrosive classification on safety data sheets, dedicated dry and cool logistics, glass-lined or fluoropolymer-compatible containment, and a documented approach to destruction of alkylating residues in waste streams. This paper addresses the chemistry, manufacturing route class, impurity and containment questions, regulatory exposure and logistics of the product.
II. Product Deep Dive: Molecular Mechanisms and Production Evolution
2.1 Physicochemical Properties and Mechanisms
The molecule is a low-viscosity liquid with a pungent, lachrymatory odour, denser than water and miscible with common aprotic solvents such as dichloromethane, toluene and acetonitrile. It reacts vigorously with water, alcohols and amines, and this dual reactivity defines both its utility and its hazard. Specification therefore centres on assay, on the absence of hydrolysis products and on the levels of related halogenated impurities.
- Acyl chloride reactivity: The acid chloride reacts rapidly with nucleophiles — amines, alcohols, thiols — to give amides, esters and thioesters with loss of hydrogen chloride, which must be scavenged by a tertiary amine or equivalent base. Because the reaction is exothermic and gas-evolving, downstream users design addition sequences for controlled heat release and for efficient acid capture, and they select solvents that tolerate the acid chloride without participating in it.
- Vicinal dibromide and secondary bromide reactivity: The brominated carbon skeleton provides sites for nucleophilic substitution and for base-induced elimination, which is why a molecule of this class is attractive as a three-carbon building block in heterocyclic and ring-forming chemistry. The same electrophilic character underpins the toxicological concern: compounds bearing such functionality are treated as potentially direct-acting alkylating agents and are assessed accordingly in impurity risk assessments.
2.2 Synthesis and Manufacturing Technologies
Commercial material is produced by converting the corresponding brominated carboxylic acid to the acid chloride using chlorinating reagents of the thionyl chloride, oxalyl chloride or phosphorus chloride classes, followed by vacuum distillation. Discussion is kept at the level of route class rather than operating detail, because the commercially relevant questions are engineering ones: how acidic off-gas is abated, how residual chlorinating reagent and inorganic by-products are removed, and how moisture ingress is excluded through the entire train.
- Off-gas abatement and materials of construction: Chlorination liberates acidic gases including hydrogen chloride and, depending on the reagent, sulphur oxides or phosphorus-containing vapours, so a compliant plant requires multi-stage scrubbing with appropriate scrubbing liquor and continuous emission monitoring. Because hydrogen chloride is generated again during hydrolysis of the product and in downstream use, materials of construction throughout are glass-lined steel, PTFE or similarly fluoropolymer-lined systems, or high-nickel alloys, with ordinary stainless steel avoided in wetted service.
- Distillation, hydrolytic control and finishing: Purification is by vacuum distillation to limit thermal exposure, since elevated temperatures promote dehydrohalogenation and darkening. The product is then handled, analysed and filled under dry inert gas with moisture excluded at every transfer, and specifications typically cover assay by titration or chromatography, identity confirmation, free acid and related halogenated impurities. Residual chlorinating reagent is a particular concern because it alters downstream stoichiometry and can generate unexpected by-products.
2.3 Core Application Matrix
- Pharmaceutical building block: The compound is used in process research and development as a three-carbon acylating and alkylating unit for constructing heterocyclic scaffolds, and for introducing brominated side chains that are elaborated in subsequent steps. Demand is campaign-based and tied to specific development programmes, so volumes move in discrete steps as programmes advance rather than smoothly with market growth.
- Agrochemical intermediate: Brominated propionyl frameworks appear in the development chemistry of crop-protection actives, where the bromine atoms provide leaving-group chemistry for ring formation. Volumes are similarly campaign-driven and are sensitive to the progress of individual registration programmes in the European Union, the United States and Brazil.
- Custom synthesis and research use: Because quantities are small and specifications are programme-specific, much of the trade is conducted as custom synthesis or toll manufacture under confidential disclosure, with material supplied either as research-use-only grade for early development or to good manufacturing practice expectations once a programme enters clinical supply.
III. Global Market Supply-Demand Landscape and Export Trends
3.1 Demand Drivers and Market Shifts
Demand is driven by the number and stage of development programmes requiring this building block rather than by macroeconomic indicators. The structural trend favouring suppliers is the continued outsourcing of hazardous and highly reactive chemistry to specialist CDMOs, since many pharmaceutical companies no longer maintain in-house capability for handling potent alkylating agents at scale. The countervailing trend is the industry's preference for designing such reagents out of processes where alternatives exist, which caps long-term volume growth.
3.2 Capacity Distribution and Export Flows
Supply is concentrated among custom-synthesis specialists and bromination-focused fine-chemical producers in China and India, with European CDMOs serving customers who require European REACH coverage, short logistics and direct audit access. Chinese producers offer the broadest scale-up capacity and competitive pricing for research-grade and early-development quantities, while Indian producers combine bromination experience with GMP-aware quality systems. European supply is limited in volume but preferred where containment, audit and regulatory proximity dominate the decision.
3.3 Market Bifurcation and Pricing Dynamics
The market divides between research-use-only material, supplied in gram to kilogram quantities with a standard certificate of analysis, and campaign material produced under quality agreements with validated methods and change control. The price differential reflects analytical and documentation workload rather than manufacturing cost. Pricing is additionally sensitive to bromine availability, which is concentrated in few producing regions.
IV. In-depth Analysis of Global Compliance and Regulatory Barriers
The compliance burden has three layers. Chemical-control registration — REACH in Europe, TSCA in the United States — establishes the right to place the substance on the market. Hazard communication governs classification, labelling and transport, and for a corrosive, moisture-reactive liquid the classification drives packaging, segregation and emergency response. The third layer is end-use quality, where pharmaceutical customers apply impurity-assessment frameworks treating electrophilic compounds as a distinct risk class.
4.1 European Market: REACH, CLP, and Sector-Specific Directives
- REACH registration and Only Representative coverage: Non-EU producers must rely on an importer's registration or appoint an Only Representative, and buyers should confirm not only that a registration exists but that the tonnage band and identified uses cover their intended application. Because volumes are small and campaign-based, registration coverage is often narrower than customers assume, and this is a recurring cause of supply interruption at the point where a programme scales up.
- CLP classification and corrosive labelling: Under CLP the substance is classified and labelled for its corrosive properties, with the GHS05 pictogram and associated hazard and precautionary statements, and safety data sheets must reflect the current adaptation to technical progress rather than legacy entries. Because hydrolysis liberates hydrogen chloride, importers should also ensure emergency response provisions cover acid-gas release, and that segregated storage from bases, alcohols and aqueous materials is specified in the safety data sheet.
4.2 North American Market: TSCA, EPA, and FDA Regulations
- TSCA inventory status and import certification: The substance must be active on the TSCA inventory for import without a premanufacture notice, and importers must make the affirmative Section 13 certification at entry. Exporters should support this with a written inventory statement, and should confirm status before first shipment since inventory position for low-volume intermediates is not always maintained by smaller producers.
- Hazard communication and end-use impurity expectations: US safety data sheets must conform to the Occupational Safety and Health Administration hazard communication standard aligned with the Globally Harmonized System. Pharmaceutical customers additionally apply ICH M7 reasoning to potentially genotoxic impurities, deriving compound-specific acceptable intakes and requiring suppliers to disclose impurity structures so that the assessment can be completed, which is often more constraining than any chemical-control regulation.
4.3 The Critical Hurdle: Quality Control and Safety Limits
Compliance Warning: The binding constraints are containment and impurity qualification, not assay. Buyers should require, before order placement, an occupational exposure band and a health-based exposure limit derived from a documented toxicological assessment, together with evidence that the supplying plant operates at the corresponding containment level; a supplier unable to state an exposure limit is not qualified for potent-alkylator chemistry. The certificate of analysis must report assay by a defined method, free acid, related halogenated impurities and water content, since hydrolysis during storage silently reduces effective assay. Pharmaceutical customers should expect to conduct an ICH M7 assessment covering the compound and its impurities, and should confirm that residual reactive species are controlled to the derived acceptable intake. Waste streams containing alkylating residues require dedicated destruction before discharge, and this should be verified in supplier audits rather than assumed.
V. Green Trade Barriers and ESG in Manufacturing
Production generates acidic off-gas, halogenated aqueous effluent and spent scrubbing liquor, all of which require treatment before discharge, and European customers increasingly request evidence of abatement performance and effluent management during qualification.
5.1 Carbon Footprint and Circular Economy
The carbon profile is driven by energy for vacuum distillation, by the embodied emissions of brominating and chlorinating reagents, and by the treatment of halogenated waste. Circularity is limited in practice because halogenated streams are destroyed rather than recovered, though recovery of hydrogen chloride as a saleable acid stream and solvent recovery from the finishing train are both genuine levers with measurable footprint benefit.
5.2 Sustainable Sourcing and Traceability
Traceability expectations focus on bromine source, route class disclosure and batch-level linkage between certificate and production record, together with change-control notification for any route or reagent modification. Customers also increasingly require end-use declarations and responsible-supply screening before shipping potent alkylating agents, and reputable suppliers treat that screening as a condition of supply rather than an administrative burden.
VI. Supply Chain Resilience and Export Logistics
This is a corrosive, moisture-reactive liquid, so logistics design is the principal determinant of whether material arrives in specification. Hydrogen chloride liberated by trace moisture attacks steel, generates pressure in sealed containers and degrades assay simultaneously, which means packaging, headspace management and temperature control must be specified explicitly rather than left to standard practice.
6.1 Packaging Standards and Moisture/Contamination Control
- Compatible containment and closure systems: Material is supplied in glass, fluoropolymer-lined or otherwise suitably lined containers with chemically resistant closures and, for larger volumes, in lined drums certified for corrosive liquids. Headspace is managed under dry inert gas, and closures are selected for resistance to acid vapour rather than to the liquid alone. Buyers should confirm closure compatibility explicitly, since gasket failure is a common cause of in-transit leakage.
- Dry handling, sampling and documentation integrity: Filling, sampling and analysis are performed under dry inert gas with moisture excluded at every transfer, and containers are closed immediately after filling. Each container should carry a label cross-referencing the batch on the certificate of analysis, and certificates should report water content alongside assay so that recipients can distinguish manufacturing variability from hydrolytic loss in transit.
6.2 Dangerous Goods Identification and Transit Protocols
The substance is regulated for transport as a corrosive material, and classification must be verified against the current safety data sheet for each shipment; it moves with the correct UN number, packing group, marking and labelling, and documentation under the IMDG Code, ADR or IATA Dangerous Goods Regulations, including segregation from bases and aqueous or oxidising materials. Transit protocols emphasise cool, dry conditions and avoidance of long dwell times in humid ports.
VII. Enterprise Global Expansion Strategy Guide
Suppliers competing in this product win on containment credibility, analytical disclosure and programme support rather than on unit price.
- Invest in documented containment capability: Establish an occupational exposure banding system, derive health-based exposure limits, and be able to evidence the corresponding containment level during customer audits. This is the single most decisive qualification criterion for potent alkylating intermediates and cannot be substituted by price advantage.
- Disclose impurity structures to enable customer assessment: Pharmaceutical customers cannot complete ICH M7 assessments without structural information. Suppliers who provide impurity identities, a defined analytical method and change-control commitment shorten qualification cycles substantially and become the specified source as programmes scale.
- Offer a graded RUO-to-GMP pathway: Campaign value is captured by supporting a programme from early research through clinical supply. Producers able to supply research-use-only material quickly and then transition the same route into good manufacturing practice expectations, with validated methods and a quality agreement, retain the customer through the highest-volume phase.
VIII. Conclusion
2,3-Dibromopropionyl chloride is a campaign-driven, high-containment intermediate whose commercial dynamics reflect its hazard profile more than its market size. Suppliers that can evidence containment, disclose impurity structures and maintain specification through dry, cool logistics capture programmes at the development stage and retain them through scale-up, while those competing only on price are confined to the least demanding research-grade segment.
Buyers should qualify on containment and analytical disclosure before price: require an exposure band and health-based exposure limit, a certificate reporting assay, free acid, related halogenated impurities and water, and change-control notification for any route modification. Regulatory exposure is manageable — REACH registration or Only Representative coverage in Europe, TSCA active status and Section 13 certification in the United States — but the corrosive classification and alkylating character impose packaging, segregation and waste-destruction obligations that must be verified at the supplying site.
IX. Industry Resource Connection and Supplier Ecosystem
Powered by Guidechem
This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.
Relying on Guidechem's extensive global database, we have mapped the core participants in the current global 2,3-Dibromopropionyl chloride supply chain:
- China — bromination and custom-synthesis capacity: Chinese producers provide the broadest scale-up capacity and competitive pricing for research and early-development quantities, frequently within bromination-focused fine-chemical complexes. The strongest participants have invested in lined containment, multi-stage off-gas scrubbing and the analytical disclosure pharmaceutical customers require.
- India — GMP-aware custom synthesis: Indian CDMOs combine bromination experience with quality systems oriented to regulated customers, English-language documentation and established audit practice, and are frequently selected for programmes expected to progress into clinical supply.
- European Union — containment-led and audit-accessible supply: European custom-synthesis specialists supply lower volumes at premium prices but provide EEA-held REACH registrations, documented containment and occupational exposure banding, and direct audit access, which often decides selection for programmes under quality agreements.
Disclaimer: The content of this white paper is compiled based on public market data and regulatory information available as of 2026. Global chemical regulations are subject to dynamic adjustments. In actual export operations, enterprises must consult professional regulatory advisors or relevant competent authorities to obtain the latest compliance guidance.